CRISPR in 2025: Clinical Use, Regulatory Pressure, and Future Promise

from Biotech Blueprint · host Katerina Roznik

Welcome back to Biotech Blueprint!In this week’s special episode, I teamed up with the Biotech Capital Compass to examine where gene editing stands today, scientifically, commercially, and clinically. This marks the start of a multi-part series on gene therapies, viewed through both scientific and investment lenses.Subscribe to Biotech Blueprint and Biotech Capital Compass.

Episode metadata supplied by the publisher feed · Published Jul 18, 2025

Embed this episode

Attribution link and audio player

Ready to play

CRISPR in 2025: Clinical Use, Regulatory Pressure, and Future Promise

0:00 56:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Research in Action Oracle Corporation "Research in Action" explores the dynamic world of life sciences, covering drug discovery, clinical trials, therapeutic development, and the pivotal role of real-world data and technology in connecting clinical research with patient care. Hear insightful conversations with scientists, clinicians, and leaders from pharma, biotech, and health.

Frequently Asked Questions

How long is this episode of Biotech Blueprint?

This episode is 56 minutes long.

When was this Biotech Blueprint episode published?

This episode was published on July 18, 2025.

Can I download this Biotech Blueprint episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!